NIH Locks Doors on Pain and Cancer Grant Reviews
Published Date: 1/28/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in early 2026 to review and decide on important grant applications related to pain research, cell biology, and cancer studies. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or new costs.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
NIH grant review dates set
The NIH Center for Scientific Review will review and evaluate grant applications on February 27, 2026 and March 3–6, 2026 (multiple panels listed). These virtual meetings will decide which grant applications move forward and therefore affect researchers and institutions that applied for funding.
Meetings closed to public for privacy
The listed NIH review meetings are closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) because discussions could disclose confidential trade secrets or personal information. That means members of the public cannot attend these virtual review sessions.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-01689 — National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Heads up! The National Heart, Lung, and Blood Advisory Council meeting got a makeover: it’s now happening earlier on March 25, 2026, switching from in-person to virtual, and moving to a new Bethesda address. This change affects anyone interested in the meeting and means you can join online instead of traveling. Some parts of the meeting will still be private, so mark your calendars and get ready to tune in from wherever you are!
Next: 2026-01691 — WisdomTree Digital Trust, WisdomTree Securities, Inc., WisdomTree Digital Management, Inc., and WisdomTree Transfers, Inc.; Notice of Application
WisdomTree companies want permission to let their broker-dealer buy and sell shares of a special government money market fund that aims to keep its share price steady at $1.00. This change affects investors who buy these shares and could speed up trading with some new joint arrangements. If no one objects by February 20, 2026, the plan will move forward without a hearing.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in